缔脉生物医药科技(上海)有限公司 DMED BIOPHARMACEUTICAL CO. LTD.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
dMed raises nearly US$50 million in Series B financing to strengthen and expand its clinical operations capability and global infrastructure 2019-10-16 15:15
1